Researchers found that zeaxanthin, long associated with eye health, may also boost the body’s immune response against cancer.

Researchers have harnessed the power of artificial intelligence to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens.

Cemacabtagene ansegedleucel, an allogeneic chimeric antigen receptor (CAR) T-cell therapy, is being investigated in relapsed/refractory large B-cell lymphoma. The investigational allogeneic chimeric ...

FRIDAY, Sept. 12, 2025 (HealthDay News) — A common nutrient found in leafy greens and corn may do more than protect eyesight. New research shows that zeaxanthin, a plant-derived carotenoid, can ...

The company has already been testing the autologous cell therapy, LioCyx-M004, in patients with certain liver cancers.

Cancer scientists have been working against the clock for decades to outsmart a disease that comes back more powerfully after ...

Researchers mapped immune cells from centenarians, their offspring, and younger controls across three cohorts using multi-omics single-cell profiling. They found that centenarians retain leaner helper ...